Category: Intellectual property
-
Diagnostics Firm Licenses Severe Food Allergy Gene Research
28 April 2014. Diagnovus LLC, a molecular diagnostics developer in Nashville, is licensing research on food allergies to detect a severe type of allergic condition based on a patient’s genetics. Financial terms of the deal with Cincinnati Children’s Hospital Medical Center that conducted the research were not disclosed. The test will analyze a patient’s genome…
-
Gecko-Inspired Adhesive Sticks to Wide Range of Materials
18 April 2014. Materials scientists and biologists at University of Massachusetts in Amherst developed an adhesive technology that attaches heavy loads to a variety of surfaces, yet can still be easily removed and reused. The journal Advanced Materials published yesterday online the work of the team led by polymer scientist Alfred Crosby (paid subscription required).…
-
Patent Awarded for Unwanted Internal Tissue Removal Device
18 April 2014. Savonas Inc., a medical technology accelerator in Sausalito, California, received a patent for a device that safely removes unwanted biological material from internal body cavities during minimally invasive surgeries. The U.S. Patent and Trademark Office granted patent number 8,696,621 on 15 April 2014 to two inventors, including Savonas’s CEO Larry Gerrans. The…
-
U.S. Patent Granted for Simple Dry-Powder Drug Inhaler
7 April 2014. Medical device manufacturer Hovione International in Lisbon, Portugal, received a patent for its inhaler for administering respiratory drugs in dry powder form. U.S. Patent and Trademark Office awarded patent 8,677,992 on 25 March to three inventors and assigned to Hovione International. Among the inventors is Peter Villax, the company’s vice-president for innovation.…
-
Patent Awarded for Cancer Antibody Delivery Technology
2 April 2014. The U.S. Patent and Trademark Office awarded a patent for a technology that connects antibodies and cancer drugs to target and deliver treatments directly to tumor cells. Patent number 8,685,383 was awarded yesterday to nine inventors and assigned to Mersana Therapeutics Inc., a biopharmaceutical company in Cambridge, Massachusetts. Timothy Lowinger, Mersana’s chief…
-
Start-Up Company Licenses University Stroke Drug Research
10 March 2014. Zocere Inc. in Albuquerque, New Mexico is licensing a neurological protein from University of New Mexico for development into a drug to protect ischemic stroke victims from extensive brain damage. Financial terms of the deal with the university’s technology transfer office were not disclosed. Nearly 800,000 people in the U.S. have a stroke each…
-
Patent Granted for RNA-Interference to Treat Scar Tissue
5 March 2014. RXi Pharmaceuticals Corp., a biotechnology company in Westborough, Massachusetts, received a patent for its technology based on RNA-interference to treat skin scars, including surgical scars. Patent number 8,664,189 was awarded yesterday by the U.S. Patent and Trademark Office to seven inventors and assigned to RXi Pharmaceuticals. RXi develops therapies with a technology…
-
Pharma Alliance Extends Cancer Antibodies to Eye Disorders
4 March 2014. Santen Pharmaceutical Co. in Osaka, Japan is licensing antibodies developed as a cancer therapy by Tracon Pharmaceuticals in San Diego as treatments for eye diseases. Tracon is expected to earn $10 million in an upfront payment from Santen, as well as undisclosed milestone payments and royalties. Tracon develops biologic therapies for cancer,…
-
Artificial Muscle Created from Fishing Line, Thread Material
20 February 2014. An international team of materials scientists and engineers developed high-strength artificial muscles from materials found into ordinary fishing line and sewing thread. The consortium from University of Texas in Dallas, University of British Columbia in Vancouver, Canada, and colleagues from China, Turkey, Australia, and Korea published their findings today in the journal…
-
Science-Based Enterprises: Great Ideas Beat Venture Capital
14 February 2014. Three entrepreneurs starting companies based on science described how they got their businesses off the ground, with ground-breaking science in many cases more important than a large stash of venture capital. San Diego entrepreneurs John Newsam, Irwin Jacobs, and Han Cao told of their start-up business experiences today at a session of…